Acasă › Tulburare depresivă majoră › New York › New York City
Studii clinice pentru Tulburare depresivă majoră în New York City, NY
36 studii pentru Tulburare depresivă majoră caută participanți în și în jurul orașului New York City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
În curs de recrutareFaza 3
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
În curs de recrutareFaza 3
- Adams Clinical Harlem, New York
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
În curs de recrutareFaza 3
- Fieve Clinical Research Inc, New York
- Adams Clinical Harlem, New York
- Manhattan Behavioral Medicine, New York
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
În curs de recrutareFaza 3
- Manhattan Behavioral Medicine, New York
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
În curs de recrutareFaza 3
- Fieve Clinical Research Inc, New York
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
În curs de recrutareFaza 2
- Ima Clinical Research - Nyc Midtown, New York
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
În curs de recrutareFaza 3
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
DBS for TRD With the Medtronic Percept PC
În curs de recrutare
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Pattern Separation in Major Depressive Disorder
În curs de recrutareFaza 1
- New York State Psychiatric Institute (NYSPI), New York
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
În curs de recrutareFaza 2
- Seaport Investigator Site, New York
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
În curs de recrutareFaza 3
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
În curs de recrutareFaza 2
- Draig Clinical Site, New York
- Draig Clinical Site, New York
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
În curs de recrutare
- Mount Sinai Hospital, New York
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
În curs de recrutareFaza 2
- Draig Clinical Site, New York
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
În curs de recrutareFaza 3
- Neurocrine Clinical Site, New York
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
În curs de recrutareFaza 3
- Neurocrine Clinical Site, New York
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
În curs de recrutareFaza 2
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
În curs de recrutareFaza 3
- Clinical Research Site, New York
- Clinical Research Site, New York
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
În curs de recrutareFaza 3
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
În curs de recrutare
- NYU Langone Health, New York
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
În curs de recrutareFaza 2
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
tDCS: Sleep to Mood in Depression (S2M-D)
În curs de recrutare
- NYU Langone Health, New York
Triage Survey for Psychiatry Research Eligibility
În curs de recrutareStudiu observațional
- Adams Clinical, Harlem, New York
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
În curs de recrutareFaza 2
- The Medical Research Network, LLC, New York
Aβ Dynamics in LLMD
În curs de recrutareFaza 4
- NYU Langone Health, New York
Maintenance rTMS for Depression (Maitr-De)
În curs de recrutare
- Weill Cornell Medicine, New York
Neutralizing Interleukin (IL)-6
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- Icahn School of Medicine at Mount Sinai, New York
Mindfulness-Based fMRI Neurofeedback for Depression
În curs de recrutare
- Columbia University Irving Medical Center, New York
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
În curs de recrutare
- Weill Cornell Medicine, New York
Biomarker-guided rTMS for Treatment Resistant Depression
În curs de recrutareFaza 3
- Weill Cornell Medicine, New York
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
În curs de recrutare
- NYU Langone Health, New York
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
În curs de recrutare
- Icahn School of Medicine at Mount Sinai, New York
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
În curs de recrutareFaza 2
- Icahn School of Medicine at Mount Sinai, New York
Neural Circuit Effects of Ketamine in Depression
În curs de recrutareFaza 4Voluntari sănătoși bineveniți
- Icahn School of Medicine at Mount Sinai, New York
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
În curs de recrutareFaza 2
- Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
În curs de recrutareFaza 4
- Clinical Research Site, New York
Studii pentru Tulburare depresivă majoră în alte orașe
- Boston, MA31 studii
- Atlanta, GA25 studii
- Philadelphia, PA23 studii
- Orlando, FL19 studii
- Miami, FL18 studii
- Chicago, IL17 studii
- Tampa, FL17 studii
- San Diego, CA16 studii
- Houston, TX16 studii
- Little Rock, AR14 studii
- Austin, TX13 studii
- Las Vegas, NV13 studii
Alte studii în New York City
- Cancer de sân136 studii
- Cancer pulmonar cu celule non-pătrate121 studii
- Cancer (toate tipurile)109 studii
- Cancer de prostată103 studii
- Cancer metastatic93 studii
- Cancer colorectal78 studii
- Cancer ovarian69 studii
- Cancer pulmonar60 studii
- Mielom multiplu60 studii
- Cancer pancreatic60 studii
- Cancer endometrial52 studii
- Leucemie mieloasă acută51 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.